Atyr Pharma Inc experienced a somewhat steady performance in the stock market.
52-week price history of ATYR Stock
A stock’s 52-week high and low prices can reveal much about its current status and future trajectory. Atyr Pharma Inc’s current trading price is -13.21% away from its 52-week high, while its distance from the 52-week low is 265.49%. The stock’s price range during this period has spanned from $1.42 to $5.98. In the Healthcare sector, the Atyr Pharma Inc’s shares surpassed a trading volume of approximately 1.45 million for the day, which was noticeably lower compared to the average daily volume of 9.1.65 million over the past three months.
Market Capitalization and Financial Performance: An In-Depth Look
Atyr Pharma Inc (ATYR) has experienced a quarterly rise of 38.03% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 461.93M and boasts a workforce of 59 employees.
Making Sense of Trading Volume and Moving Average Data
Examining ATYR’s Debt-to-Equity Ratio: What You Need to Know
The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for ATYR stands at 0.17. Similarly, the long-term debt-to-equity ratio is also 0.16.
ATYR Stock Price Performance Analysis
The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. This year’s metric has recorded a Price increase of 43.37%. However, over the past six months, we’ve seen a weaker performance of 71.29%. The price of ATYR fallen by 48.71% over the last 30 days. And in the last five days, it has fallen by -4.42%.
